Clinical Trials Directory

Trials / Completed

CompletedNCT04756362

IN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE)

Potential Impact in Clinical Practice of Early Exclusion Protocols for Acute Myocardial Infarction With High Sensitivity Troponin T in Different Scenarios (IN-HOspital Program to SystematizE Chest Pain Protocol-IN HOPE)

Status
Completed
Phase
Study type
Observational
Enrollment
5,497 (actual)
Sponsor
Hospital Samaritano Paulista · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multicenter Nationwide Study for Analysis of the Potential Impact in Clinical Practice of Early Exclusion Protocols for Acute Myocardial Infarction with High Sensitivity Troponin T

Detailed description

Chest pain is the main clinical complaint in emergency room visits and represents the most common symptom of Acute Myocardial Infarction, which is the main cause of death in Brazil and worldwide. Although most patients with chest pain do not have a final diagnosis of AMI, they remain under observation until the diagnosis of AMI is excluded. The most current strategy recommended for rapid AMI exclusion uses high-sensitivity cardiac troponin T at time zero and one hour later. However, some points that have not yet been properly evaluated in previous studies can be evaluated in the current study: * Evaluation of the early exclusion protocol (0 -1 hour) in a Brazilian population * Evaluation of the early exclusion protocol (0 -1 hour) in isolation and associated with traditional risk scores (TIMI, GRACE, HEART and EDACS) * Systematic evaluation of the early exclusion protocol (0 -1 hour) in patients without chest pain but with a pre-defined condition of suspected AMI * Evaluation of the prognostic value of an isolated high-sensitivity cardiac troponin T \< 5 ng/L in a diverse population.

Conditions

Timeline

Start date
2020-07-23
Primary completion
2022-01-31
Completion
2022-07-31
First posted
2021-02-16
Last updated
2022-08-03

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04756362. Inclusion in this directory is not an endorsement.